SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$4.61
-0.29 (-5.92%)
▼
5d:
-2.74%
30d:
-22.13%
90d:
-72.88%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
42.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $4.61, which is considered oversold relative to its 30-day fair value range of $5.17 to $6.46. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.4) compared to its historical average (27.4). Remarkably, the market is currently pricing in an annual earnings decline of 21.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $4.57. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: SNWV scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $40.00 (+706.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $4.57. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: SNWV scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $40.00 (+706.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.17 -
$6.46
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 706.5% below Wall St target ($40.00)
- CAUTION: Bottoming setup, but lagging the sector by 22% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$5.17 -
$6.46
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.57
Resistance Level
$5.97
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.41
Wall Street Target
$40.00
(+706.5%)
Revenue Growth (YoY)
-3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
34.7%
Valuation Discount vs History
-21.2% cheaper
PE vs Historical
13.4 vs 27.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-21.2%
(market-implied from PE analysis)
1-Year Target
$4.46
(-10%)
2-Year Target
$4.02
(-19%)
3-Year Target
$3.62
(-27%)
3-Yr Target (if PE normalizes)
(PE: 13→27)
$7.39
(+49%)
📈
Valuation based on Current Earnings
Trailing PE: 5.85 | Current EPS (TTM): $0.81
Bull Case
$2.61
(-43%)
Analyst growth -50.0%, PE expands to 6.4
Base Case
$2.37
(-49%)
Market implied -50.0%, PE stable at 5.9
Bear Case
$3.22
(-30%)
Severe decline -20.0%, PE contracts to 5.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.4 to 27.4
Stabilization Target:
$10.14
(+104.4%)
PE Expansion Potential:
+104.4%
Share & Embed Analysis
Last updated: August 23, 2026 9:06 AM ET
Data refreshes hourly during market hours. Next update: 10:06 AM
Data refreshes hourly during market hours. Next update: 10:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 37 SELL |
